Details for Patent: 9,539,333
✉ Email this page to a colleague
Summary for Patent: 9,539,333
Title: | Sustained release polymer |
Abstract: | A polymer and a method for its preparation are provided. The polymer comprises poly(lactide), poly(lactide/glycolide) or poly(lactic acid/glycolic acid) segments bonded by ester linkages to both ends of an alkanediol core unit. The polymer is for use in a controlled release formulation for a medicament, preferably leuprolide acetate. The controlled release formulation is administered to a patient as a subcutaneous depot of a flowable composition comprising the polymer, a biocompatible solvent, and the medicament. Controlled release formulations comprising the polymer release leuprolide for treatment of prostate cancer patients over periods of 3-6 months. |
Inventor(s): | Dunn; Richard L. (Fort Collins, CO) |
Assignee: | Tolmar Therapeutics, Inc. (Fort Collins, CO) |
Application Number: | 15/014,810 |
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; |
Drugs Protected by US Patent 9,539,333
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,539,333
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 259217 | ⤷ Sign Up | |||
Austria | 296088 | ⤷ Sign Up | |||
Austria | 458469 | ⤷ Sign Up | |||
Australia | 1331200 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |